Instil Bio (UK) Limited
Therapeutic area: Oncology & Immune engineering
Company: Private & not listed
Cellular Therapeutics Ltd is focused on providing patient specific immunotherapy, allowing the patient’s own immune system to be harnessed in order to fight disease. Specifically CTL is developing Adoptive Cell Therapy (ACT) and has expertise in cGMP manufacturing and engineering of cells ready for patient treatment. The aim of the company is to transform these therapies from highly specialist cases to main stream treatments for life-threatening diseases.